Grade 2 or 3 PPE occurred in 30 ( 58 % ) of 52 evaluable patients ; in six patients adverse effects occurred on the placebo side but not on the treatment side , whereas one patient developed palmar-plantar erythrodysesthesia on the treatment side only ( P = 0.07 ) .